Eli Lilly and Co
SIX:LLY
Eli Lilly and Co
SIX:LLY
Price:
750
CHF
2.74%
Market Cap:
CHf707.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Eli Lilly and Co
SIX:LLY
|
US |
|
GuocoLand Ltd
SGX:F17
|
SG |
|
B
|
Barton Gold Holdings Ltd
ASX:BGD
|
AU |
|
Metalstech Ltd
ASX:MTC
|
AU |
|
M
|
Mitsubishi Electric Corp
OTC:MIELF
|
JP |
|
Taylor Wimpey PLC
LSE:TW
|
UK |
|
Power Finance Corporation Ltd
NSE:PFC
|
IN |
|
L
|
Liuzhou Iron & Steel Co Ltd
SSE:601003
|
CN |
|
Ribo Fashion Group Co Ltd
SSE:603196
|
CN |
|
Forward Industries Inc
NASDAQ:FORD
|
US |
Multiples-Based Value
The Multiples-Based Value of one
LLY
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 750 CHF,
Eli Lilly and Co
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LLY Multiples-Based Value
LOCKED
Multiples Across Competitors
LLY Competitors Multiples
Eli Lilly and Co Competitors
Eli Lilly and Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
SIX:LLY
|
901.8B CHF | 13.8 | 43.7 | 29.5 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.5 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF | 5.4 | 21.6 | 13.4 | 17.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD | 2.6 | 20.9 | 7.9 | 10.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.6 | 17.6 | 7.4 | 9.1 | |
| FR |
|
Sanofi SA
PAR:SAN
|
100.2B EUR | 2.1 | 12.7 | 10.6 | 10.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
